{"id":6829,"date":"2025-04-30T09:56:56","date_gmt":"2025-04-30T04:26:56","guid":{"rendered":"https:\/\/lakshmishree.com\/news\/?p=6829"},"modified":"2025-04-30T09:56:59","modified_gmt":"2025-04-30T04:26:59","slug":"strides-pharma-gains-after-buying-4-us-drug-approvals-to-expand-product-range","status":"publish","type":"post","link":"https:\/\/lakshmishree.com\/news\/strides-pharma-gains-after-buying-4-us-drug-approvals-to-expand-product-range\/","title":{"rendered":"Strides Pharma Gains After Buying 4 US Drug Approvals to Expand Product Range"},"content":{"rendered":"\n<p>Strides Pharma shares went up slightly on April 30 morning after the company announced that its US-based arm has acquired four approved drug applications (ANDAs) for the American market. The share was trading at Rs 657.40 on the BSE, up by 0.74 percent at 09:24 AM.<\/p>\n\n\n\n<p>These ANDAs have been purchased from Nostrum Laboratories Inc., a US-based company. The total value of this deal is around USD 2.075 million, which is approximately Rs 176 crore.<\/p>\n\n\n\n<p>The newly acquired products include both liquid and solid oral drugs. They are used to treat a variety of conditions such as urinary tract infections (UTIs), pain, allergy symptoms, Attention Deficit Disorder (ADD\/ADHD), and narcolepsy. Strides said that two of these four drugs are already commercial and expected to be launched within the next 12 months.<\/p>\n\n\n\n<p>The acquisition will enhance Strides&#8217; market footprint in the field of niche and difficult-to-manufacture drugs in the US market where demand is high for them.<\/p>\n\n\n\n<p>The stock has been very volatile over the past 52 weeks. It touched its 52-week high of Rs 1,675.25 on October 17, 2024, and its 52-week low of Rs 530.70 on January 27, 2025. Currently, the stock is trading around 61 percent lower than its 52-week high and around 24 percent higher than its 52-week low.<\/p>\n\n\n\n<p>Even with the gain today, the stock has declined by more than 56 percent in the last half-year period. The current market value of the company has come down to Rs 6,058.78 crore.<\/p>\n\n\n\n<p>Do you have a news tip for Lakshmishree reporters? Please email us at <a class=\"\">media@lakshmishree.com<\/a>.<br><sup><sub>Source: <a href=\"https:\/\/www.moneycontrol.com\/news\/business\/markets\/strides-pharma-shares-in-focus-on-acquiring-4-andas-for-us-market-13008510.html\" target=\"_blank\" data-type=\"link\" data-id=\"https:\/\/www.moneycontrol.com\/news\/business\/markets\/strides-pharma-shares-in-focus-on-acquiring-4-andas-for-us-market-13008510.html\" rel=\"noreferrer noopener\">Moneycontrol<\/a>.<\/sub><\/sup><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Strides Pharma shares went up slightly on April 30 morning after the company announced that its US-based arm has acquired four approved drug applications (ANDAs) for the American market. The share was trading at Rs 657.40 on the BSE, up by 0.74 percent at 09:24 AM. These ANDAs have been purchased from Nostrum Laboratories Inc., [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":6830,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"set","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[50],"tags":[1162],"class_list":["post-6829","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-indian-market","tag-strides-pharma-us-drug-approval"],"_links":{"self":[{"href":"https:\/\/lakshmishree.com\/news\/wp-json\/wp\/v2\/posts\/6829","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lakshmishree.com\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lakshmishree.com\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lakshmishree.com\/news\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/lakshmishree.com\/news\/wp-json\/wp\/v2\/comments?post=6829"}],"version-history":[{"count":1,"href":"https:\/\/lakshmishree.com\/news\/wp-json\/wp\/v2\/posts\/6829\/revisions"}],"predecessor-version":[{"id":6831,"href":"https:\/\/lakshmishree.com\/news\/wp-json\/wp\/v2\/posts\/6829\/revisions\/6831"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/lakshmishree.com\/news\/wp-json\/wp\/v2\/media\/6830"}],"wp:attachment":[{"href":"https:\/\/lakshmishree.com\/news\/wp-json\/wp\/v2\/media?parent=6829"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lakshmishree.com\/news\/wp-json\/wp\/v2\/categories?post=6829"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lakshmishree.com\/news\/wp-json\/wp\/v2\/tags?post=6829"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}